- Home
- Publications
- Publication Search
- Publication Details
Title
Adalimumab: A Review in Chronic Plaque Psoriasis
Authors
Keywords
Psoriasis, Adalimumab, Tumour Necrosis Factor Inhibitor, Ustekinumab, Dermatology Life Quality Index
Journal
DRUGS
Volume 75, Issue 18, Pages 2119-2130
Publisher
Springer Nature
Online
2015-11-19
DOI
10.1007/s40265-015-0503-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk Factor Analysis for the Immunogenicity of Adalimumab Associated with Decreased Clinical Response in Chinese Patients with Psoriasis
- (2015) H Chiu et al. ACTA DERMATO-VENEREOLOGICA
- Immunogenicity of Biologic Treatments for Psoriasis: Therapeutic Consequences and the Potential Value of Concomitant Methotrexate
- (2015) Michael E. Farhangian et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Psoriasis: classical and emerging comorbidities
- (2015) Maria de Fátima Santos Paim de Oliveira et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk
- (2015) Hervé Lebrec et al. CURRENT MEDICAL RESEARCH AND OPINION
- On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasis
- (2015) L. Puig JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study
- (2015) Akihiko Asahina et al. JOURNAL OF DERMATOLOGY
- Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2015) Richard B. Warren et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis
- (2015) Logan S. D'Souza et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis
- (2015) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics
- (2015) P. Sator et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities
- (2015) I. M. G. J. Bronckers et al. PEDIATRIC DRUGS
- CCL20andIL22Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis
- (2015) Ari M. Goldminz et al. JAMA Dermatology
- ‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
- (2014) J.M.P.A. van den Reek et al. BRITISH JOURNAL OF DERMATOLOGY
- Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
- (2014) R. Gniadecki et al. BRITISH JOURNAL OF DERMATOLOGY
- Biological Drugs for the Treatment of Moderate-to-Severe Psoriasis by Subcutaneous Route: Determining Statistical Equivalence According to Evidence-Based Methods
- (2014) Andrea Messori et al. CLINICAL DRUG INVESTIGATION
- Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption
- (2014) K.B. Gordon et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy
- (2014) B.E. Strober et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry
- (2014) J.M.P.A. van den Reek et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
- (2014) Wei Zhang et al. PHARMACOECONOMICS
- Biological Therapies for the Treatment of Severe Psoriasis in Patients with Previous Exposure to Biological Therapy: A Cost-Effectiveness Analysis
- (2014) Laura M. Sawyer et al. PHARMACOECONOMICS
- Effect of Treating Psoriasis on Cardiovascular Co-Morbidities: Focus on TNF Inhibitors
- (2013) Shannon Famenini et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Cost Effectiveness of Biologic Therapies for Plaque Psoriasis
- (2013) Christine S. Ahn et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study
- (2013) M. Esposito et al. BRITISH JOURNAL OF DERMATOLOGY
- The effect of adalimumab on key drivers in the pathogenesis of psoriasis
- (2013) A.G.M. Hendriks et al. BRITISH JOURNAL OF DERMATOLOGY
- Antidrug antibodies in psoriasis: a systematic review
- (2013) L. Hsu et al. BRITISH JOURNAL OF DERMATOLOGY
- Biological treatments for moderate-to-severe psoriasis: indirect comparison
- (2013) M. Galván-Banqueri et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis
- (2013) U. Mrowietz et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points
- (2013) L. Puig et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis
- (2013) Stef P. Menting et al. JAMA Dermatology
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of the Tumor Necrosis Factor-α Antagonist Adalimumab on Arterial Inflammation Assessed by Positron Emission Tomography in Patients With Psoriasis
- (2012) Robert Bissonnette et al. Circulation-Cardiovascular Imaging
- Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study
- (2012) K. Papp et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis
- (2011) Craig Leonardi et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials
- (2011) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
- (2011) Bruce E. Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
- (2011) Kenneth Gordon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis
- (2011) C. Ferrándiz et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities
- (2010) Alexa B. Kimball et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis
- (2010) Lidian L. A. Lecluse et al. ARCHIVES OF DERMATOLOGY
- Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet
- (2010) Craig Leonardi et al. ARCHIVES OF DERMATOLOGY
- Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy
- (2010) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement
- (2010) L. Soegaard-Madsen et al. BRITISH JOURNAL OF DERMATOLOGY
- A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study
- (2010) D. Thaçi et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
- (2010) K. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life
- (2010) Kim A. Papp et al. CLINICAL DRUG INVESTIGATION
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
- (2010) Akihiko ASAHINA et al. JOURNAL OF DERMATOLOGY
- Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept
- (2010) Robert Bissonnette et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis
- (2010) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab
- (2009) Katherine F Croom et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases
- (2009) Leanne M. Johnson-Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- TNF-mediated inflammatory disease
- (2007) JR Bradley JOURNAL OF PATHOLOGY
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started